PACLX
Price
$37.74
Change
+$0.01 (+0.03%)
Updated
Oct 17 closing price
RPBAX
Price
$28.24
Change
-$0.03 (-0.11%)
Updated
Oct 17 closing price
Ad is loading...

PACLX vs RPBAX

Header iconPACLX vs RPBAX Comparison
Open Charts PACLX vs RPBAXBanner chart's image
T. Rowe Price Capital Appreciation Adv
Price$37.74
Change+$0.01 (+0.03%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Balanced
Price$28.24
Change-$0.03 (-0.11%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PACLX vs RPBAX Comparison Chart
Loading...
VS
PACLX vs. RPBAX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACLX is a StrongBuy and RPBAX is a Buy.

FUNDAMENTALS
Fundamentals
PACLX has more cash in the bank: 65.3B vs. RPBAX (4.77B). RPBAX pays higher dividends than PACLX: RPBAX (1.95) vs PACLX (1.77). PACLX was incepted earlier than RPBAX: PACLX (20 years) vs RPBAX (85 years). PACLX is a more actively managed with annual turnover of: 65.10 vs. RPBAX (40.90). PACLX (2500) and RPBAX (2500) have matching initial minimum investment requirements. RPBAX annual gain was more profitable for investors over the last year : 21.95 vs. PACLX (18.82). PACLX return over 5 years is better than : 28.73 vs. RPBAX (26.66).
PACLXRPBAXPACLX / RPBAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years85 years-
Gain YTD12.99813.79894%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets65.3B4.77B1,370%
Annual Yield % from dividends1.771.9591%
Returns for 1 year18.8221.9586%
Returns for 3 years1.24-0.00-33,658%
Returns for 5 years28.7326.66108%
Returns for 10 years58.2343.30134%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLSCX41.580.38
+0.92%
Fidelity Advisor Leveraged Co Stk C
SGRKX44.500.12
+0.27%
Allspring Growth Admin
RPEBX63.710.10
+0.16%
American Funds New Perspective R2E
BIPIX68.74N/A
N/A
ProFunds Biotechnology UltraSector Inv
PSVKX19.40N/A
N/A
PGIM Quant Solutions Small-Cap Val R4